title: [Hypolipidemic treatment after myocardial infarction].
abstract: Treatment of hyperlipidaemia is even more important after than before myocardial infarction. Currently available data should be confirmed by larger studies including women and lasting over 10 years. Analysis of the results would be facilitated by studying comparable groups with respect to left ventricular function and severity of the coronary disease. The total serum cholesterol should optimally be under 2 g/l and the LDL-cholesterol under 1.30 g/l. However, coronary artery disease is a multifactorial condition and the correction of only one predisposing factor, albeit a major one, is not sufficient for effective prevention.
authors.affiliation: Service de cardiologie, CHRU Pasteur, Nice.
authors.forename: P
authors.initials: P
authors.lastname: Morand
authors.forename: J P
authors.initials: JP
authors.lastname: Roquebrune
authors.forename: A
authors.initials: A
authors.lastname: Fredenrich
mesh_terms: D000368:Aged; D002784:Cholesterol / Q000097:blood; D004036:Diet, Atherogenic; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D017202:Myocardial Ischemia / Q000209:etiology / Q000517:prevention & control*; D012307:Risk Factors
chemical_list: D000960:Hypolipidemic Agents; D008074:Lipoproteins; D002784:Cholesterol
vernacular_title: Traitement hypolipémiant après infarctus du myocarde.